Welcome to Pharmacelsus - Your reliable CRO for in vitro ADME and in vivo pharmacokinetic services

Pharmacelsus provides the pharmaceutical and biotech industry with a range of high quality drug discovery and development solutions enabling them to make decisions at critical steps of the drug development process.

Pharmacelsus Service Portfolio

Pharmacelsus is your partner for GLP and non-GLP studies. The service portfolio encompasses in vitro and in vivo studies for preclinical drug discovery and development.

• Discovery lead optimisation services / in vitro ADME characterization
• Membrane transporter assays
• Drug-drug interaction studies
• In vivo pharmacokinetics & pharmacodynamics
• Bioanalytical services
• GLP method validation
• Metabolite characterization
• Target-based bioassays (endocrinology, diabetes)
• In vitro services for target finding & biological profiling
• Cytotoxicity testings (genotoxicity, immunotoxicity)

All services are performed as non-GLP studies - FDA and EMA relevant GLP studies on request.

Pharmacelsus’ services stand out due to their high reputation!

Individual & personal, reliable and dedicated - this is Pharmacelsus!